Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 12, 1995, Pages 3689-3698

  Morishima, Akira ^a   Grumbach, Melvin M ^c   Simpson, Evan R ^b   Fisher, Carolyn ^b   Qin, Kenan ^b  

^a The New York Presbyterian Hospital   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN;

ANIMAL CELL; ARTICLE; BODY BUILD; CASE REPORT; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; FEMALE; GENE MUTATION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; MALE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; TISSUE DISTRIBUTION; VIRILIZATION;

ADULT; AROMATASE; BASE SEQUENCE; CASE REPORT; DNA, COMPLEMENTARY; ESTROGENS; EXONS; FEMALE; HUMAN; MALE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; NUCLEAR FAMILY; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028792229     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.12.8530621     Document Type: Article

References (44)

1. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshel-woodMM, Graham-Lorence S, Amameh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE. 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 15:342-355.
2. Shozu M, Akasofu K, Harada, T, Kubota Y.1991 A new cause of female pseudohermaphroditism: placental aromatase deficiency, Clin Endocrinol Metab. 72:560-566.
3. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. 1993 Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA. 90:11673-11677.
4. Conte FA, Grumbach MM, Ito Y, Fisher, CR, Simpson ER. 1994 A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 78:1287-1292.
5. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1056-1061.
6. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER. 1988 Isolation of a full length cDNA insert encoding human aromatase system cytochrome P450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA. 85:8948-8952.
7. Means GD, Mahendroo M, Corbin CJ, et al. 1989 Structural analysis of the gene encoding human aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. J Biol Chem. 264:19385-19391.
8. Lephart ED, Simpson ER. 1991 Assay of aromatase activity. Methods Enzymol. 206:477-483.
9. McNatty KP, Smith DM, Maoris A, Osathanondh R, Ryan KJ. 1979 The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vitro and in vivo. J Clin Endocrinol Metab. 49:851-860.
10. Silverberg SJ, Gartenberg F, Jacobs TP, et al. 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab. 80:723-728.
11. Southard RN, Morris JD, Mahan JD, et al. 1991 Bone mass in healthy children: measurement with quantitative DXA. Radiology. 179:735-738.
12. Graham-Lorence S, Amanteh B, White RE, Peterson JA, Simpson ER. 1995 A three dimensional model of aromatase cytochrome P450. Protein Sci. 4:1065-1080.
13. Harada N, Ogawa H, Shozu M, et al. 1992 Biochemical and molecular genetic analyses on placental aromatase (P450arom) deficiency. J Biol Chem. 267:4781-4785.
14. Harada N, Ogawa H, Shozu M, Yamada K. 1992 Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet. 51:666-672.
15. Ryan KJ. 1959 Biological aromatization of steroids. J Biol Chem. 234:268-272.
16. Inkster SE, Brodie AMH. 1989 Immunocytochemical studies of aromatase in early and full-term human placental tissue: comparison with biochemical assays. Biol Reprod. 41:889-898.
17. McNatty KP, Maoris A, Reinhold VN, Dc Grazia C, Osathanondh R, Ryan KJ. 1979 Metabolism of androstenedione by human ovarian tissue in vitro with particular reference to 5α-reductase and aromatase activity. Steroids. 34:429-434.
18. Kelch RP, Jenner MR, Weinstein RL, Kaplan SL, Grumbach MM. 1972 Estradiol and testosterone secretion by human, simian and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome. J Clin Invest. 51:824-830.
19. Schindler AE, Ebert A, Friedrich E. 1972 Conversion of androstenedione to estrone bv human fat tissue. J Clin Endocrinol Metab. 35:627-630
20. Siiteri PK, Seron-Ferre M. 1978Secretion and metabolism of adrenal androgens to estrogens. In: James VHT, Serio M, Guisti G, Martini L, eds.The endocrine function of the human adrenal cortex. New York: Academic Press; 251-264.
21. Longcope C, Pratt JH, Scheneider SH, Fineberg SE. 1978 Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab. 46:146-152.
22. Schweikert HU, Milewich L, Wilson JD. 1975 Aromatization of androstenedione by isolated human hairs. J Clin Endocrinol Metab. 40:413-417.
23. Ryan KJ, Naftolin F, Reggy V, Flores F, Petro Z. 1972 Estrogen formation in the brain. Am J Obstet Gynecol. 114:454-460.
24. Evans CT, Ledesma DB, Schulz TZ, Simpson ER, Mendelson CR. 1986 Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA. Proc Natl Acad Sci USA. 83:6387-6391.
25. Grumbach MM, Ducharme JR. 1960 The effects of androgens on fetal sexual development: Androgen-induced female pseudoher-maphrodism. Fertil Steril. 11:157-180.
26. Grumbach MM, Conte FA. 1992 Disorders of sex differentiation. In: Wilson JD, Foster DW, eds.Williams' textbook of endocrinology, 8th ed. Philadelphia: Saunders; 853-951.
27. Ehrmann DA, Barnes RB, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:322-353.
28. McNatty KP, Baird DT. 1978 Relationship between follicle stimulating hormone, androstenedione and estradiol in human follicular fluid. J Endocrinol. 76:527-531.
29. Lubhahn DB, Moyer JS, Golding TS, et al. 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA. 90:1162-1166.
30. Finkelstein JS, O'Dea LS, Whitcomb RW, Crowley WF. 1991 Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and GnRH deficient men. J Clin Endocrinol Metab. 74:621-628.
31. Bagatell CJ, Dahl KD, Bremner WJ. 1994 The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl. 15:15-21.
32. Turner RT, Riggs BL, Spelsbery TC. 1994 Skeletal effects of estrogen. Endocr Rev. 15:275-300.
33. Horowitz MC. 1993 Cytokines and estrogen in bone: anti-osteopo-rotic effects. Science. 260:626-627.
34. Prince RL. 1994 Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocr Rev. 15:301-309.
35. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB. 1992 Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab74:1396-1400.
36. Godsland IF, Gangar KF, Walton C, et al. 1993 Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism. 42:846-853.
37. Sharp SC, Diamond MP. 1995 Sex steroids and diabetes. Diabetes Rev. 1:318-342.
38. The Writing Group for the PEP1 Trial. 1995Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 273:199-208.
39. Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ. 1994 Physiological levels of estradiol stimulate plasma high density lipoprotein 2 cholesterol levels in normal men. J Clin Endocrinol Metab. 78:855-861.
40. Bagatell CJ, Heim anJR, Matsumoto AM, Rivier JE, Bremner WJ. 1994 Metabolic and behavioral effects of high dose exogenous testosterone in healthy men. J Clin Endocrinol Metab. 79:561-567.
41. Aascheman H, Gooren LJ, Megans JA, Nauta J, Kloosterfoer HJ, Eikelboom F. 1994 Serum testosterone is the major determinant of the male-female differences in serum levels of high-density lipoprotein HDD cholesterol and HDL2 cholesterol. Metabolism. 43:935-939.
42. MacLusky NJ, Naftolin F. 1981 Sexual differentiation of the central nervous system. Science. 211:1294-1303.
43. Hodgkin J. 1991 Sex determination and the generation of sexually dimorphic nervous systems. Neuron. 6:177-185.
44. Pilgrim C, Reisert J. 1992 Differences between male and female brains-developmental mechanisms and implications. Horm Metab Res. 24:353-359.